GMI現況

GMI小孢子靈芝免疫調節蛋白質結合多種創新技術,
己取得結構,檢驗與多種應用專利,同時持續累積發表學術文獻並取得多項國際認證。

GMI Certification
Use of immunomodulatory protein from Ganoderma in inhibiting fibrosis 2021-11-16

ABSTRACT:

The present invention provides a method of preventing or treating fibrosis in a subject , comprising administering an effective amount of an immunomodulatory protein derived from Ganoderma lucidum , Ganoderma lucidum , Ganoderma tsugae , Ganoderma microsporum or Ganoderma sinensis to the subject , thereby preventing or treating a fibrosis .

 

 

出處聯結:US11058746B2

聯絡我們
聯絡位置

222 新北市深坑區北深路三段270巷12號8樓之1

聯絡電話

+886-2-2662-0148